Protective compunds in animal models of trigeminal activation and neurodegeneration [PDF]
Vámos Enikő
core
Mitochondrial Dysfunction in Neurodegenerative Diseases. [PDF]
Yang HM.
europepmc +1 more source
Small HSPs at the crossroad between protein aggregation, autophagy and unconventional secretion: clinical implications and potential therapeutic opportunities in the context of neurodegenerative diseases. [PDF]
Bonavita R+6 more
europepmc +1 more source
The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition. [PDF]
Cheng CY+4 more
europepmc +1 more source
Huntingtin CAG repeat size variations below the Huntington's disease threshold: associations with depression, anxiety and basal ganglia structure. [PDF]
Vater M+10 more
europepmc +1 more source
Lysosomal Channels as New Molecular Targets in the Pharmacological Therapy of Neurodegenerative Diseases <i>via</i> Autophagy Regulation. [PDF]
Tedeschi V+5 more
europepmc +1 more source
Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington's disease. [PDF]
Gu Y, Sung K, Wu C.
europepmc +1 more source
Ubiquitin specific peptidase 11 knockdown slows Huntington's disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway. [PDF]
Gao B, Jing Y, Li X, Cong S.
europepmc +1 more source
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification. [PDF]
Harding RJ+10 more
europepmc +1 more source
Brain-Derived Neurotrophic Factor (BDNF) in Huntington's Disease: Neurobiology and Therapeutic Potential. [PDF]
Azman KF, Zakaria R.
europepmc +1 more source